Related Experiment Video
Updated: Jul 9, 2025
06:10
Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
3.3K
Subclavian Impella 5.5 implant for perioperative left ventricular dysfunction
Barbara Karner1, Melanie Arnreiter1, Birgit Zirngast1
1Division of Cardiac Surgery, Department of Surgery, Medical University of Graz, Auenbruggerplatz 5/5, A-8036 Graz, Austria.
Multimedia Manual of Cardiothoracic Surgery : MMCTS
|November 28, 2023
Summary
This study details the successful implantation and management of the Impella 5.5 heart pump through the right subclavian artery. This approach aided a patient with severe left ventricular dysfunction after cardiac surgery.
Area of Science:
- Cardiovascular Surgery
- Medical Device Technology
- Hemodynamic Support
Background:
- Severe left ventricular dysfunction poses significant challenges post-cardiac surgery.
- Weaning from cardiopulmonary bypass requires careful hemodynamic management.
- Minimally invasive access routes are crucial for device implantation.
Observation:
- A 72-year-old patient presented with severe left ventricular dysfunction.
- The Impella 5.5 device was considered for hemodynamic support.
- Access via the right subclavian artery was chosen for implantation.
Findings:
- The Impella 5.5 device was successfully implanted via the right subclavian artery.
- The patient's postoperative management was detailed.
- Successful weaning from cardiopulmonary bypass was achieved with device support.
Implications:
- Right subclavian artery access is a viable route for Impella 5.5 implantation.
- This method offers an alternative for patients with complex cardiac conditions.
- Effective postoperative management is key to successful outcomes with mechanical circulatory support.
